 |
Panel Member: Return on Investments in Health Research (2007.01)
Aled Edwards, University of Toronto
Aled Edwards, Ph.D., is a noted Canadian structural biologist. He is Banbury Professor at the Banting and Best Department of Medical Research, the University of Toronto, Canada and the Director and CEO of the international Structural Genomics Consortium, an Anglo-Canadian-Swedish public-private partnership, created to increase the number of protein structures of relevance to human health available in the public domain, and. In each of the past two years, the SGC has been responsible for depositing over 20% of the new human protein structures to the public database.
Dr. Edwards co-founded Affinium Pharmaceuticals, a Toronto-based anti-infectives company, Jaguar Biosciences, a diagnostic company focused on hepatitis C, and Scate Consultants Inc, a company that commercializes bioremediation intellectual property. He also serves as a scientific advisor on the Canadian television drama ReGenesis. He has served in management and advisory capacities for several biotechnology companies and international research consortia.
|
|